What is Barrington Research's Forecast for OPCH Q2 Earnings?

Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Research analysts at Barrington Research issued their Q2 2026 earnings per share (EPS) estimates for Option Care Health in a report released on Thursday, February 27th. Barrington Research analyst M. Petusky expects that the company will post earnings of $0.40 per share for the quarter. Barrington Research has a "Outperform" rating and a $38.00 price objective on the stock. The consensus estimate for Option Care Health's current full-year earnings is $1.22 per share. Barrington Research also issued estimates for Option Care Health's Q3 2026 earnings at $0.45 EPS, Q4 2026 earnings at $0.46 EPS and FY2027 earnings at $1.89 EPS.

A number of other equities analysts have also recently issued reports on the stock. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. UBS Group initiated coverage on Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price on the stock. JPMorgan Chase & Co. increased their target price on Option Care Health from $38.00 to $40.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Finally, Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and an average price target of $32.88.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded up $0.46 during midday trading on Monday, hitting $33.96. 1,699,328 shares of the stock were exchanged, compared to its average volume of 1,584,820. Option Care Health has a twelve month low of $21.39 and a twelve month high of $34.54. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a 50 day moving average price of $28.70 and a 200-day moving average price of $28.06. The stock has a market cap of $5.78 billion, a P/E ratio of 28.54, a PEG ratio of 2.30 and a beta of 1.35.

Institutional Trading of Option Care Health

Hedge funds have recently added to or reduced their stakes in the business. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health during the 4th quarter worth about $26,000. UMB Bank n.a. increased its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Signaturefd LLC raised its stake in Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the period. Quadrant Capital Group LLC boosted its holdings in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.64% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.